Abstract
Through association with the interoceptive effects of drugs of abuse, neutral environmental stimuli can gain motivational properties themselves, becoming conditioned reinforcers that can evoke craving and relapse to drug seeking. Nucleus accumbens dopamine (DA) neurotransmission plays an important role in the reinforcing effect of cocaine itself, but, unlike nucleus accumbens glutamate, it seems not to mediate the conditioned reinforcing properties of cocaine-paired stimuli. Dorsal striatal DA transmission, in contrast, has been shown to be enhanced during cocaine seeking under a second-order schedule of reinforcement, which depends on the conditioned reinforcing properties of cocaine-associated stimuli. Therefore, the aim of the present study was to evaluate the role of DA and glutamate transmission in the dorsal striatum in cue-controlled cocaine seeking. Infusion of the DA receptor antagonist α-flupenthixol into the dorsal striatum decreased cocaine seeking under a second-order schedule of reinforcement. In addition, intradorsal striatal infusion of the AMPA/kainate (KA) receptor antagonist LY293558 (3SR, 4aRS, 6RS, 8aRS-6-[2-(iH-tetrazol-5-yl)ethyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroiso-quinoline-3-carboxylic acid), but not the NMDA receptor antagonist AP-5, also decreased cue-controlled cocaine seeking. These data show that stimulation of DA and AMPA/KA receptors in the dorsal striatum is critical for well established drug seeking that depends on the reinforcing effects of cocaine-associated stimuli. In addition, given the importance of the dorsal striatum in stimulus–response habit learning, these data suggest that the habitual or compulsive quality of persistent drug seeking depends on dorsal striatal mechanisms.
- dorsal striatum
- dopamine receptor
- AMPA receptor
- NMDA receptor
- cocaine
- reinforcement
- second-order schedule
- habit
Introduction
Drug-paired conditioned stimuli (CSs) can, as conditioned reinforcers, maintain drug seeking and precipitate drug craving and relapse (Stewart et al., 1984; Ehrman et al., 1992; Carter and Tiffany, 1999; Everitt and Robbins, 2000; Schindler et al., 2002; Panlilio et al., 2005). In rodents and primates, second-order schedules of reinforcement provide a well established method of investigating the neurobiology of drug seeking that is under the control of drug-associated CSs (Goldberg et al., 1975; Everitt and Robbins, 2000; Schindler et al., 2002). Indeed, cocaine seeking under a second-order schedule of reinforcement in humans shares many similarities to that observed in rats and monkeys (Panlilio et al., 2005).
Although the mesencephalic dopamine (DA) projection to the nucleus accumbens (NAcc) plays a pivotal role in the reinforcing effect of cocaine (Roberts et al., 1977; Pettit et al., 1984; Caine et al., 1995; Rodd-Henricks et al., 2002), this system appears not to mediate the conditioned reinforcing properties of cocaine-paired stimuli, because NAcc DA efflux is not correlated with responding for cocaine cues (Neisewander et al., 1996; Ito et al., 2000). Moreover, intra-NAcc infusion of a DA receptor antagonist did not alter cocaine seeking under a second-order schedule of reinforcement (Di Ciano and Everitt, 2004c), although infusion of an AMPA/kainate (KA) glutamate receptor antagonist did (Di Ciano and Everitt, 2001), suggesting that glutamatergic afferents to the NAcc, rather than NAcc DA, mediate the conditioned reinforcing effects of cocaine cues (Park et al., 2002).
In contrast, a clear DAergic correlate of cue-controlled cocaine seeking was seen in the dorsal striatum, in which DA efflux increased markedly in rats responding under a second-order schedule of reinforcement (Ito et al., 2002). The dorsal striatum has also been found to be activated during cue-elicited cocaine craving in humans (Garavan et al., 2000), and imaging studies in primates have shown that, with prolonged cocaine self-administration, dorsal regions of the striatum become progressively more engaged by the drug (Letchworth et al., 2001; Porrino et al., 2004). It has also been shown that, after lengthy drug experience, drug seeking develops a habitual or compulsive quality (Deroche-Gamonet et al., 2004; Di Ciano and Everitt, 2004a; Vanderschuren and Everitt, 2004). In view of the role of the dorsal striatum in the establishment of stimulus–response (S-R) habits (Packard and Knowlton, 2002; White and McDonald, 2002; Yin et al., 2004), these observations together suggest that the dorsal striatum mediates what has been hypothesized to be the habitual nature of well established drug seeking (Tiffany, 1990; Robbins and Everitt, 1999; Everitt et al., 2001). Therefore, in the present study, we investigated directly the role of the dorsal striatum in cue-controlled cocaine seeking by infusing the DA receptor antagonist α-flupenthixol, the AMPA/KA receptor antagonist LY293558 (3SR, 4aRS, 6RS, 8aRS-6-[2-(iH-tetrazol-5-yl)ethyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroiso-quinoline-3-carboxylic acid), or the NMDA receptor antagonist AP-5 into the dorsal striatum in rats responding under a second-order schedule of reinforcement.
Materials and Methods
Animals. Adult male Lister Hooded rats (Charles River Laboratories, Kent, UK) weighing 300–350 g at the time of surgery were individually housed under a reversed 12 h light/dark cycle (lights on at 7:00 P.M.). On the day before the start of testing, rats were placed on a restricted diet of 20 g/d lab chow (Purina), sufficient to maintain body weight and growth throughout the experiment. Water was available ad libitum, and food was given within 2 h after daily testing. Experiments were performed between 9:00 A.M. and 7:00 P.M., 5–6 d/week. Experiments were conducted in accordance with the United Kingdom 1986 Animals (Scientific Procedures) Act (Project License PPL 80/1324).
Apparatus. Rats were tested in operant chambers (29.5 × 32.5 × 23.5 cm; Med Associates, St. Albans, VT). Each chamber was equipped with two 4-cm-wide retractable levers. The two levers were 12 cm apart and 8 cm from the grid floor. Above each lever was a cue light (2.5 W, 24 V), and a red house light (2.5 W, 24 V) was located on the opposite wall. The floor of the chamber was covered with a metal grid. The testing chamber was placed within a sound- and light-attenuating box, equipped with a ventilation fan that also screened external noise. SILASTIC tubing shielded with a metal spring extended from each animal's intravenous catheter to a liquid swivel (Stoelting, Wood Dale, IL) mounted on an arm fixed outside of the operant chamber. Tygon tubing extended from the swivel to a Razel infusion pump (Semat Technical, Herts, UK) located adjacent to the external chamber. The operant chamber was controlled by software written by Rudolf Cardinal and Mike Aitken (University of Cambridge, Cambridge, UK) in the language C++ using the Whisker control system (Cardinal and Aitken, 2001).
Intravenous surgery. Rats were anesthetized with ketamine hydrochloride (100 mg/kg, i.p.; Ketaset) and xylazine (9 mg/kg, i.p.; Rompun), supplemented with ketamine as needed (∼20 mg/kg), and implanted with a single catheter in the right jugular vein. Catheters were made from 22 gauge cannulas with elongated ends. SILASTIC tubing (0.012 inner diameter) was secured to the bottom end of the cannula, and the top was fixed to nylon mesh. The mesh end of the catheter was sutured subcutaneously on the dorsum. All surgical instruments were thoroughly sterilized before surgery. To prevent infection, rats were treated postsurgically with 10 mg/kg Baytril (Bayer, Wuppertal, Germany) subcutaneously for 8 d. For details, see Caine et al. (1992).
Procedure. Daily experimental testing began 7–10 d after intravenous surgery. Active and inactive levers were counterbalanced between left and right sides for individual animals. “Priming” injections of cocaine were never given. During initial training, rats acquired a lever press response for cocaine (0.25 mg/infusion, 0.1 ml/5 s) under a fixed-ratio (FR1) (timeout, 20 s) schedule of reinforcement. On this schedule, each lever press resulted in illumination of the stimulus light above the lever, retraction of both levers, and extinction of the house light for 20 s. After this 20 s interval, the house light was again illuminated, the stimulus light was extinguished, and the two levers were again inserted into the testing box. Presses on the inactive lever had no programmed consequences but were recorded to assess general levels of activity. After 3 d of stable responding on this schedule, a second-order schedule of the type FRx-(FRy:S) was gradually introduced, such that x number of unit schedule requirements resulted in a cocaine infusion, and y number of lever presses resulted in illumination of the stimulus light for 1 s within the unit schedule. Therefore, under a second-order schedule, rats were presented with two stimuli: (1) a 1 s illumination of the stimulus light after y responses, and (2) a 20 s illumination of the stimulus light during cocaine infusion. The schedule requirements were gradually increased, beginning with a value of y set at 1 and a value of x of 5; each lever press resulted in a 1 s CS presentation, and, after five such CS presentations, rats received a cocaine infusion and associated 20 s presentation of this stimulus light. Subsequently, the response requirements increased to FR10 (FR1:S), FR10(FR2:S), FR10(FR4:S), FR10(FR7:S), and FR10(FR10:S). After stable responding under the final schedule, a fixed-interval (FI) [FI15 min(FR10:S)] schedule was introduced, and rats were allowed to stabilize and establish individual patterns of responding under this schedule. Under this schedule, cocaine was available after completion of an FR of 10 responses after an overall FI 15 min had timed out; during the FI 15 min, each FR10 response was reinforced by presentation of the drug-paired CS. Animals were permitted five infusions of cocaine per day under this schedule.
Intracranial surgery and microinfusions. After the acquisition of stable responding under an FI15(FR10:S) schedule, rats were anesthetized with ketamine hydrochloride (100 mg/kg, i.p.; Ketaset) and xylazine (9 mg/kg, i.p.; Rompun) and positioned into a stereotaxic frame (David Kopf Instruments, Tujunga, CA). Guide cannulas, consisting of 24 gauge thin-walled stainless steel tubing (Cooper's Needleworks), were implanted bilaterally, aimed 2.0 mm above the dorsal striatum [+1.2 mm anteroposterior; ±3.0 mm mediolateral; –3.0 mm dorsoventral; incisor bar at –3.3 mm (Paxinos and Watson, 1986)]. Cannulas were secured with stainless steel screws and dental acrylic; 29 gauge wire stylets (Cooper's Needleworks) were inserted into the guide cannulas to maintain patency. After reacquisition of stable responding under an FI15(FR10:S) schedule of reinforcement, intracerebral microinfusions (0.5 μl) were made through a 28 gauge injector (Semat Technical) lowered to the site of injection (–5.0 mm) over 90 s simultaneously to both sides of the brain using a syringe pump (model 975A; Harvard Apparatus, Holliston, MA), followed by a 60 s postinfusion diffusion time. After all infusions, stylets were replaced, and the animal was left in a holding box for 5 min before testing. Before drug infusions and behavioral assessment, all rats received one or two infusions of phosphate buffer on separate days to habituate them to the injection procedure. Intracerebral infusions of the DA receptor antagonist α-flupenthixol (Sigma, Poole, UK), the AMPA/KA antagonist LY293558 (a gift from Eli Lilly & Co., Indianapolis, IN), and the NMDA receptor antagonist AP-5 (Sigma) were given after at least 2 d of stable responding subsequent to the phosphate buffer infusions. α-Flupenthixol was dissolved in distilled water, and LY293558 and AP-5 were dissolved in phosphate-buffered water (composition of 0.07 mm Na2HPO4 and 0.028 mm NaH2PO4, giving an approximate pH of 7.5). AP-5 was given in a single dose (2 μg/side), and α-flupenthixol (5, 10, and 15 μg/side) and LY293558 (0.05, 0.1, and 0.2 μg/side) were given in three doses plus vehicle, according to a counterbalanced, Latin square design (Keppel, 1991), with infusions of each dose being separated by at least 2 d of stable responding without treatment. After completion of the α-flupenthixol dose–effect study, six rats were shifted back to an FR1 (timeout, 20 s) schedule of reinforcement. In these animals, the effect of α-flupenthixol (10 and 15 μg/side) on cocaine self-administration were assessed in 2 h sessions during which every lever press resulted in a cocaine infusion. Drug doses were based on previous studies in our laboratory (Di Ciano and Everitt, 2001, 2004c; Di Ciano et al., 2001).
Histological assessment of cannulas placements. At the end of testing, rats were anesthetized with an overdose of sodium pentobarbitone (1.5 ml/animal, i.p., Euthatal; Rhône-Mérieux, Hertfordshire, UK) and perfused transcardially with isotonic saline, followed by 4% paraformaldehyde in 0.2 m phosphate buffer. Brains were then removed and postfixed before being transferred to a 20% sucrose solution in 0.01 m PBS for ∼24 h before being sectioned at 60 μm using a freezing microtome. Every third section was mounted and stained with cresyl violet, and placements were verified under a light microscope.
Statistical analyses. For all self-administration sessions, the number of active and inactive lever presses was recorded. For the second-order schedule of self-administration, lever presses for the first 15 min interval, when rats were responding for cocaine CSs while in a drug-free condition, are presented as the mean ± SEM number of responses. For the FR1 schedule, total number of active and inactive presses during the 2 h session are presented as mean ± SEM number of responses. All measures were analyzed with repeated-measures ANOVA for drug dose. When appropriate, post hoc comparisons were made using Student–Newman–Keuls tests.
Results
Histology
Figure 1 shows the location of the tips of injection cannulas within the dorsolateral striatum (filled circles; n = 13) established by microscopical examination of cresyl violet-stained coronal sections of the brain by an observer blind to the behavioral results. No animals were discarded from the analysis because of cannula misplacements.
Second-order schedule of cocaine self-administration
α-Flupenthixol
Infusion of α-flupenthixol into the dorsal striatum resulted in a significant, dose-dependent suppression of responding on the active lever during the first 15 min interval of the session (F(3,21) = 4.05; p < 0.05). Post hoc comparisons revealed that 15 μg of α-flupenthixol significantly decreased the number of responses made (Fig. 2, left). The number of inactive lever presses was not affected by α-flupenthixol (F(3,21) = 2.71; NS) (Fig. 2, right). Under an FR1 schedule of reinforcement, α-flupenthixol at 10 and 15 μg significantly increased the number of active lever presses (vehicle, 42.2 ± 5.6; 10 μgof α-flupenthixol, 61.7 ± 6.2; 15 μg of α-flupenthixol, 67.5 ± 2.9; F(2,10) = 23.23; p < 0.001) but did not alter the number of inactive presses (vehicle, 1.5 ± 1.5; 10 μgof α-flupenthixol, 0.8 ± 0.7; 15 μgof α-flupenthixol, 3.2 ± 2.0; F(2,10) = 2.71; NS).
LY293558
After infusion of LY293558 into the dorsal striatum, the number of active responses was decreased (F(3,12) = 3.58; p < 0.05) to a level that was significantly different from vehicle at doses of 0.1 and 0.2 μg/side (Fig. 3, left). Analysis of the number of inactive lever presses revealed no effect of LY293558 (F(3,12) = 1.94; NS) (Fig. 3, right).
AP-5
Infusion of AP-5 into the dorsal striatum was without effect on responding on the active lever (vehicle, 180.0 ± 10.5 responses; AP-5, 205.3 ± 90.3 responses; F(1,3) = 0.10; NS) or on the inactive lever (vehicle, 4.8 ± 2.5 responses; AP-5, 9.8 ± 2.1 responses; F(1,3) = 2.63; NS).
Discussion
The results of the present study show that blockade of DA or AMPA/KA receptors in the dorsal striatum inhibits cocaine seeking underpinned by response-contingent presentations of drug-paired CSs in rats (Everitt and Robbins, 2000). These findings may have considerable implications for our understanding of the psychobiology of drug addiction.
Mesostriatal DA neurons are known to be activated by reward-predictive CSs (Schultz, 2002), and noncontingent, pavlovian presentation of cocaine cues has been shown to increase NAcc DA efflux (Gratton and Wise, 1994; Kiyatkin and Stein, 1996; Duvauchelle et al., 2000; Ito et al., 2000; Weiss et al., 2000; Phillips et al., 2003) (but see Brown and Fibiger, 1992; Bradberry et al., 2000). However, DA efflux in the NAcc is not altered during cocaine seeking when cocaine-associated CSs are presented contingent on responding (Neisewander et al., 1996; Ito et al., 2000). These observations are consistent with our previous findings that the integrity of the NAcc DA innervation is not critical for responding with conditioned reinforcement but is required for the potentiation of conditioned reinforcement by psychostimulant drugs (Taylor and Robbins, 1986; Wolterink et al., 1993). In contrast, responding for cocaine under a second-order schedule of reinforcement is accompanied by enhanced DA efflux in the dorsal striatum (Ito et al., 2002), and infusion of a DA receptor antagonist into the dorsal striatum, but not the NAcc, reduced cocaine-seeking under a second-order schedule of reinforcement (Di Ciano and Everitt, 2004c; present study). Thus, the present data add to the evidence suggesting that the way in which cocaine-associated CSs are presented (contingent or noncontingent) determines whether DA neurons projecting to NAcc or dorsal striatum are activated.
Unlike NAcc DA, NAcc AMPA/KA receptor-mediated glutamate neurotransmission has been implicated in cue-controlled cocaine seeking. Glutamate efflux in the NAcc has been found to increase when animals are exposed to a cocaine-paired environment (Hotsenpiller et al., 2001), and intra-NAcc administration of an AMPA/KA antagonist attenuates the expression of cocaine conditioned place preference (Kaddis et al., 1995), cocaine seeking under a second-order schedule of reinforcement (Di Ciano and Everitt, 2001, 2004c), and cocaine-primed reinstatement of responding for cocaine cues (Park et al., 2002). The present study provides direct evidence that dorsal striatal glutamate, through stimulation of AMPA/KA receptors, is also important for the performance of cocaine seeking supported by cocaine-associated conditioned reinforcers.
It is unlikely that the effects of α-flupenthixol or LY293558 on responding for cocaine cues were secondary to changes in locomotor activity. There were no effects of α-flupenthixol or LY293558 on inactive lever presses. In addition, intradorsal striatum infusion of α-flupenthixol did not suppress, but dose dependently increased, lever pressing for cocaine under an FR1 schedule. These results suggest that DA receptor blockade in this dorsal striatal region attenuates the primary reinforcing effect of cocaine, which seems inconsistent with previous findings (Caine et al., 1995; Ikemoto, 2003), although different areas within the dorsal striatum were targeted in these studies. Thus, a specific domain within the dorsal striatum may contribute to the reinforcing effects of cocaine.
Blockade of DA and AMPA/KA receptors in the dorsal striatum disrupted cocaine seeking under a second-order schedule of reinforcement. However, the majority of studies investigating the neural basis of this behavior, as well as the cued reinstatement of extinguished cocaine seeking, have demonstrated a dependence on limbic cortical-ventral striatal circuitry, including the ventral tegmental area (VTA), amygdala, prefrontal cortex, and NAcc (Whitelaw et al., 1996; Meil and See, 1997; Weissenborn et al., 1997; Di Ciano and Everitt, 2001, 2004b; Park et al., 2002; McLaughlin and See, 2003; Fuchs et al., 2004). However, the DAergic innervation of the dorsolateral striatum targeted here arises primarily from the substantia nigra pars compacta rather than the VTA (Fallon and Moore, 1978; Gerfen et al., 1987; Oades and Halliday, 1987; Voorn et al., 2004). Moreover, this region of the dorsal striatum predominantly receives glutamatergic projections from sensorimotor cortex and central lateral thalamus but less so from prefrontal cortex, basolateral amygdala, or hippocampus (Kelley et al., 1982; Groenewegen et al., 1987; McGeorge and Faull, 1989; McDonald, 1991; Voorn et al., 2004). Therefore, our data indicate that the neural systems underlying well established cue-controlled cocaine seeking are more extensive than usually considered.
The behavior of animals responding for a first infusion of cocaine under a second-order schedule of reinforcement is controlled by the conditioned reinforcing properties of the cocaine-associated CS as well as anticipation of drug reinforcement (for review, see Everitt and Robbins, 2000). Because responding during this period of time occurs in a drug-free state, the effect of α-flupenthixol on cue-controlled cocaine seeking cannot be the result of any effect on the reinforcing properties of cocaine itself. In addition, dopaminergic lesions of the dorsal striatum or infusions of d-amphetamine into the dorsolateral striatum have no effect on the acquisition of responding for conditioned reinforcement or its potentiation by psychostimulant drugs (Taylor and Robbins, 1984, 1986; Kelley and Delfs, 1991). Rather, the dorsal striatum (Packard and McGaugh, 1996; Yin et al., 2004) including its dopaminergic (Robbins et al., 1990; Packard and White, 1991) and glutamatergic (Packard, 1999) innervation has been shown to be involved in the acquisition of S-R habits, whereby behavior becomes automatic and relatively independent of the goal: that is, it is no longer driven by an action–outcome relationship (for review, see Everitt et al., 2001; Packard and Knowlton, 2002; White and McDonald, 2002). The present findings therefore suggest that the performance of cocaine seeking as studied here may reflect the establishment of a habitual form of responding that depends on dorsal striatal processes.
Although the dorsal striatum plays a role in the performance of well established cocaine seeking, it is the ventral striatum, including the nucleus accumbens shell and the olfactory tubercle, that has been shown to be important for the initial acquisition of cocaine self-administration (Rodd-Henricks et al., 2002; Ikemoto, 2003). The nucleus accumbens core, in turn, is required for the acquisition of cocaine seeking under a second-order schedule of reinforcement (Ito et al., 2004). This apparently progressive involvement of dorsal striatal-dependent processes has also been revealed in metabolic and molecular imaging studies of primates with a prolonged history of cocaine self-administration. Thus, when comparing dopamine transporter binding or metabolic activity after 5 or 100 sessions of cocaine self-administration, it was shown that changes that were restricted to the ventral striatum early on, spread dorsally to involve the dorsal striatum, including the sensorimotor striatal domains studied here, at the chronic stage (Letchworth et al., 2001; Porrino et al., 2004). This ventral-to-dorsal intrastriatal progression of regions engaged by the self-administration of cocaine may be subserved by striato-VTA/nigro-striatal pathways, whereby ventral striatal regions influence not only their own DAergic innervation but also that of progressively more dorsal areas via their spiraling projections to DA neurons in the VTA and substantia nigra (Haber et al., 2000). In this way, cocaine-induced increases in DA in the NAcc shell can modulate DAergic activity not only in the core but also in more dorsal associative and sensorimotor domains of the striatum. This mechanism strengthens the longer the history of cocaine self-administration.
We have hypothesized that, over the course of many cycles of drug self-administration, the associative structure underlying drug seeking may reflect a shift from a goal-directed response–outcome process mediated by the ventral striatum to one dominated by a habitual, stimulus–response form of behavior that depends on the dorsal striatum (Tiffany, 1990; Robbins and Everitt, 1999; Everitt et al., 2001). This is not to imply that limbic cortical-ventral striatal mechanisms no longer contribute to cocaine seeking when well established, because we have shown that AMPA/KA receptor blockade in the NAcc core as well as DA receptor blockade in the basolateral amygdala attenuate the performance of cocaine seeking (Di Ciano and Everitt, 2001, 2004c). The NAcc core clearly mediates conditioned influences on instrumental behavior (Parkinson et al., 1999; Corbit et al., 2001; Hall et al., 2001; Ito et al., 2004) and is also critical for animals to tolerate delays to reinforcement (Cardinal et al., 2001) which are inherent in second-order schedules of reinforcement (Everitt and Robbins, 2000). We therefore hypothesize that DAergic mechanisms in the NAcc shell and core that mediate reinforcement processes and modulate limbic cortical mechanisms controlling goal-directed behavior progressively activate, consolidate, and may eventually become subordinate to a dorsal striatum-dependent habit system (Everitt et al., 2001; Porrino et al., 2004). This may explain the powerful impact that drug-associated conditioned reinforcers have on drug seeking: they support the acquisition of this behavior, helping animals and humans to bridge often long delays to primary drug reinforcement, but they also progressively engage a dorsal striatal mechanism through which responding becomes automatic. In support of this hypothesis, we have shown that rats not only readily acquire a new response reinforced by presentations of a cocaine-associated CS but also that, once acquired, responding for the conditioned reinforcer is resistant to extinction and persists for many weeks, even in the absence of additional pairings with cocaine (Weiss et al., 2001; Di Ciano and Everitt, 2004a). Thus, the neural plasticity mechanisms that are engaged by self-administered cocaine and other addictive drugs (Nestler, 2001; Kauer, 2004; Kelley, 2004) not only underlie alterations in incentive motivational or reward systems (Robinson and Berridge, 1993; Wise, 2004) but also in the associative structures underlying persistent drug seeking (Robbins and Everitt, 1999; Everitt et al., 2001).
Footnotes
This research was supported by a Medical Research Council (MRC) Programme Grant and was conducted within the Cambridge MRC Centre for Behavioral and Clinical Neuroscience. L.J.M.J.V. was a visiting scientist from the Research Institute Neurosciences Vrije Universiteit (Department of Medical Pharmacology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands), supported by a Wellcome Trust Traveling Research Fellowship. We thank Caroline Parkinson, Mercedes Arroyo, and Rachel Underwood for skillful technical assistance. We also thank Eli Lilly and Dr. H.C. Fibiger for the generous gift of LY293558.
Correspondence should be addressed to Louk J. M. J. Vanderschuren, Rudolf Magnus Institute of Neuroscience, Department of Pharmacology and Anatomy, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands. E-mail: l.j.m.j.vanderschuren{at}med.uu.nl.
DOI:10.1523/JNEUROSCI.0925-05.2005
Copyright © 2005 Society for Neuroscience 0270-6474/05/258665-06$15.00/0